The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review.

Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis (2012) 1.16

To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 1.11

Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol (2010) 1.09

Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities. J Clin Microbiol (2009) 1.08

Pre-Operative Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) Infection: A Review of the Clinical-Effectiveness and Guidelines. CADTH Technol Overv (2010) 1.04

Carriage rates of methicillin-resistant Staphylococcus aureus (MRSA) depend on anatomic location, the number of sites cultured, culture methods, and the distribution of clonotypes. Eur J Clin Microbiol Infect Dis (2010) 1.02

MRSA as an occupational disease: a case series. Int Arch Occup Environ Health (2011) 1.01

Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections. Am J Infect Control (2012) 0.97

Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta. Infect Control Hosp Epidemiol (2012) 0.96

Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis. BMJ Open (2012) 0.88

Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? Clin Infect Dis (2008) 0.83

Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit. Crit Care (2015) 0.81

Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol (2013) 0.81

Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship. Antimicrob Resist Infect Control (2012) 0.81

Active surveillance cultures for methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis (2008) 0.78

The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit. Eur J Clin Microbiol Infect Dis (2011) 0.78

Admission Screening of Methicillin-Resistant Staphylococcus aureus with Rapid Molecular Detection in Intensive Care Unit: A Three-Year Single-Centre Experience in Hong Kong. ISRN Microbiol (2013) 0.75

Use of active surveillance cultures in intensive care units. Clin Infect Dis (2009) 0.75

Current Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Elderly French People: Troublesome Clones on the Horizon. Front Microbiol (2016) 0.75

Methicillin-resistant Staphylococcus aureus: misinterpretation and misrepresentation of active detection and isolation. Clin Infect Dis (2008) 0.75

Screening and control of methicillin-resistant Staphylococcus aureus in 186 intensive care units: different situations and individual solutions. Crit Care (2011) 0.75

Challenges of applying the SHEA/HICPAC metrics for multidrug-resistant organisms to a real-world setting. Infect Control Hosp Epidemiol (2011) 0.75

Methicillin-resistant Staphylococcus aureus risk profiling: who are we missing? Antimicrob Resist Infect Control (2013) 0.75

Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol (2009) 2.86

How to write an evidence-based clinical review article. Am Fam Physician (2002) 1.71

Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative. J Bone Miner Res (2014) 1.03

Salmon calcitonin use and associated cancer risk. Ann Pharmacother (2013) 0.89

Bisphosphonate use in acute and chronic spinal cord injury: a systematic review. J Spinal Cord Med (2009) 0.86

Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative. J Clin Endocrinol Metab (2014) 0.83

Use of high flow nasal cannula on a pediatric burn patient with inhalation injury and post-extubation stridor. Burns (2005) 0.82

Osteoporosis prevalence in men varies by the normative reference. J Clin Densitom (2004) 0.82

United States adults meeting 2010 American College of Rheumatology criteria for treatment and prevention of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) (2014) 0.81

Comparative effectiveness and cost-effectiveness of strategies to screen for osteoporosis in postmenopausal women. Ann Intern Med (2011) 0.76

Bone density testing in older women. JAMA (2012) 0.75